| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8381805eba6d034fc77bd230dd02e6e2 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-465 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 |
| filingDate |
1991-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1045486cbc99453f79d03a37cd8635b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9088cb4c8ff56f665a9f457d44ec6795
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1c76eebfe47f3b992a3b22903650c0b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_185cad66e82319995f5dbc8de93d48f5 |
| publicationDate |
1992-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0471549-A2 |
| titleOfInvention |
Lipoprotein removal by soluble enzymes |
| abstract |
A therapeutically effective amount of soluble phospholipase A₂ is administered into a subject for lowering the low density lipoproteins ("LDL") in the blood. Phospholipase A₂ modifies the plasma LDL by hydrolyzing the phospholipids present in LDL. As a result, the modified LDL is rapidly removed from the bloodstream by the catabolic processes. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2722692-A1 |
| priorityDate |
1990-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |